Institut Paoli-Calmettes, 232 Bd Ste-Marguerite, 13273 Marseille Cedex 09, France. 3 Centre d'Immunologie Marseille-Luminy, Parc Scientifique & Technologique de Luminy -Case 906 -F13288 Marseille cedex 09, France. 4 Department of Surgery, p.232 ,
Gene expression profiling and clinical outcome in breast cancer, 58 Bd Charles Livon, pp.429-443, 2006. ,
Repeated observation of breast tumor subtypes in independent gene expression data sets, Proceedings of the National Academy of Sciences, vol.100, issue.14, pp.8418-8423, 2003. ,
DOI : 10.1073/pnas.0932692100
Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms, BMC Genomics, vol.7, issue.1, p.127, 2006. ,
DOI : 10.1186/1471-2164-7-127
Molecular portraits of human breast tumours, Nature, vol.406, issue.6797, pp.747-752, 2000. ,
DOI : 10.1038/35021093
Gene expression profiling predicts clinical outcome of breast cancer, Nature, vol.415, pp.530-536, 2002. ,
How basal are triple-negative breast cancers?, International Journal of Cancer, vol.9, issue.1, pp.236-240, 2008. ,
DOI : 10.1002/ijc.23518
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer, New England Journal of Medicine, vol.347, issue.25, pp.1999-2009, 2002. ,
DOI : 10.1056/NEJMoa021967
Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes, Clinical Cancer Research, vol.14, issue.16, pp.5158-5165, 2008. ,
DOI : 10.1158/1078-0432.CCR-07-4756
The Protein Kinase Complement of the Human Genome, Science, vol.298, issue.5600, pp.1912-1934, 2002. ,
DOI : 10.1126/science.1075762
A census of human cancer genes, Nature Reviews Cancer, vol.4, issue.3, pp.177-83, 2004. ,
DOI : 10.1038/nrc1299
Tyrosine Kinases as Targets for Cancer Therapy, New England Journal of Medicine, vol.353, issue.2, pp.172-187, 2005. ,
DOI : 10.1056/NEJMra044389
Sixteen-Kinase Gene Expression Identifies Luminal Breast Cancers with Poor Prognosis, Cancer Research, vol.68, issue.3, pp.767-776, 2008. ,
DOI : 10.1158/0008-5472.CAN-07-5516
Identification of Novel Kinase Targets for the Treatment of Estrogen Receptor-Negative Breast Cancer, Clinical Cancer Research, vol.15, issue.20, pp.6327-6340, 2009. ,
DOI : 10.1158/1078-0432.CCR-09-1107
Molecular Cancer http://www.molecular-cancer.com/content, p.8686, 2011. ,
The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer, Cancer Research, vol.68, issue.13, pp.5405-5413, 2008. ,
DOI : 10.1158/0008-5472.CAN-07-5206
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer, The Lancet, vol.365, issue.9460, pp.671-679, 2005. ,
DOI : 10.1016/S0140-6736(05)70933-8
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis, JNCI Journal of the National Cancer Institute, vol.98, issue.4, pp.262-272, 2006. ,
DOI : 10.1093/jnci/djj052
Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer, Cancer Research, vol.66, issue.21, pp.10292-10301, 2006. ,
DOI : 10.1158/0008-5472.CAN-05-4414
Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series, Clinical Cancer Research, vol.13, issue.11, pp.3207-3214, 2007. ,
DOI : 10.1158/1078-0432.CCR-06-2765
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts, Breast Cancer Research, vol.7, issue.6, pp.953-964, 2005. ,
DOI : 10.1186/bcr1325
From The Cover: An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival, Proceedings of the National Academy of Sciences, vol.102, issue.38, pp.13550-13555, 2005. ,
DOI : 10.1073/pnas.0506230102
Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer, Journal of Clinical Oncology, vol.24, issue.26, pp.4236-4244, 2006. ,
DOI : 10.1200/JCO.2006.05.6861
RETRACTED: Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial, The Lancet Oncology, vol.8, issue.12, pp.1071-1078, 2007. ,
DOI : 10.1016/S1470-2045(07)70345-5
FGFRI andPLAT genes and DNA amplification at 8p 12 in breast and ovarian cancers, Genes, Chromosomes and Cancer, vol.4, issue.4, pp.219-226, 1993. ,
DOI : 10.1002/gcc.2870070407
Exploration, normalization, and summaries of high density oligonucleotide array probe level data, Biostatistics, vol.4, issue.2, pp.249-264, 2003. ,
DOI : 10.1093/biostatistics/4.2.249
CM: The molecular portraits of breast tumors are conserved across microarray platforms, BMC Genomics, vol.7, issue.1, p.96, 2006. ,
DOI : 10.1186/1471-2164-7-96
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma, New England Journal of Medicine, vol.346, issue.25, pp.1937-1947, 2002. ,
DOI : 10.1056/NEJMoa012914
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers, Breast Cancer Research, vol.10, issue.2, p.15, 2009. ,
DOI : 10.1186/bcr2124
Gene Expression Profiling for Survival Prediction in Pediatric Rhabdomyosarcomas: A Report From the Children's Oncology Group, Journal of Clinical Oncology, vol.28, issue.7, pp.1240-1246, 2010. ,
DOI : 10.1200/JCO.2008.21.1268
Stromal Gene Signatures in Large-B-Cell Lymphomas, New England Journal of Medicine, vol.359, issue.22, pp.2313-2323, 2008. ,
DOI : 10.1056/NEJMoa0802885
Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer, Breast Cancer Research and Treatment, vol.23, issue.Suppl 3, pp.363-373, 2011. ,
DOI : 10.1007/s10549-010-1003-z
URL : https://hal.archives-ouvertes.fr/hal-00594464
Cluster analysis and display of genome-wide expression patterns, Proceedings of the National Academy of Sciences, vol.95, issue.25, pp.14863-14868, 1998. ,
DOI : 10.1073/pnas.95.25.14863
A gene expression signature identifies two prognostic subgroups of basal breast cancer, Breast Cancer Research and Treatment, vol.280, issue.3, pp.407-420, 2011. ,
DOI : 10.1007/s10549-010-0897-9
URL : https://hal.archives-ouvertes.fr/hal-00583558
Identification of Subtypes in Human Epidermal Growth Factor Receptor 2???Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome, Journal of Clinical Oncology, vol.28, issue.11, pp.1813-1820, 2010. ,
DOI : 10.1200/JCO.2009.22.8775
Cell-type specific gene expression profiles of leukocytes in human peripheral blood, BMC Genomics, vol.7, issue.1, p.115, 2006. ,
DOI : 10.1186/1471-2164-7-115
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles, Proceedings of the National Academy of Sciences, vol.102, issue.43, pp.15545-15550, 2005. ,
DOI : 10.1073/pnas.0506580102
Reporting Recommendations for Tumor Marker Prognostic Studies, Journal of Clinical Oncology, vol.23, issue.36, pp.9067-9072, 2005. ,
DOI : 10.1200/JCO.2004.01.0454
Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?, Nature Reviews Cancer, vol.97, issue.7, pp.545-553, 2007. ,
DOI : 10.1200/JCO.2005.04.7985
Gene expression profiling of breast cancer, Breast Cancer Research, vol.27, issue.S3, p.11, 2009. ,
DOI : 10.1200/JCO.2008.21.6887
Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer, Breast Cancer Research and Treatment, vol.120, issue.6917, pp.69-77, 2009. ,
DOI : 10.1007/s10549-008-0105-3
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer, Genome Biology, vol.8, issue.8, p.157, 2007. ,
DOI : 10.1186/gb-2007-8-8-r157
A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer, Breast Cancer Research, vol.66, issue.4, p.73, 2008. ,
DOI : 10.1158/0008-5472.CAN-06-0031
High Expression of Lymphocyte-Associated Genes in Node-Negative HER2+ Breast Cancers Correlates with Lower Recurrence Rates, Cancer Research, vol.67, issue.22, pp.10669-10676, 2007. ,
DOI : 10.1158/0008-5472.CAN-07-0539
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas, Breast Cancer Research, vol.161, issue.5, p.65, 2007. ,
DOI : 10.1016/S0002-9440(10)64476-8
Molecular Cancer http://www.molecular-cancer.com/content, p.8686, 2011. ,
How different are luminal A and basal breast cancers?, International Journal of Cancer, vol.1, issue.6, pp.1338-1348, 2009. ,
DOI : 10.1002/ijc.24055
Immunomodulation of Breast Cancer via Tumor Antigen Specific Th1, Cancer Research and Treatment, vol.41, issue.3, pp.117-121, 2009. ,
DOI : 10.4143/crt.2009.41.3.117
Gene expression profiling of breast cell lines identifies potential new basal markers, Oncogene, vol.109, issue.15, pp.2273-2284, 2006. ,
DOI : 10.1038/sj.onc.1209254
URL : https://hal.archives-ouvertes.fr/hal-01431970
Immune Regulation of Cancer, Journal of Clinical Oncology, vol.28, issue.29, pp.4531-5438, 2010. ,
DOI : 10.1200/JCO.2009.27.2146
Use of tumour-responsive T cells as cancer treatment, The Lancet, vol.373, issue.9664, pp.673-683, 2009. ,
DOI : 10.1016/S0140-6736(09)60404-9